The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer

SIMPLE SUMMARY: Identifying markers predictive of response and resistance to neoadjuvant chemotherapy (NAC) has become a major research objective. Ductal carcinoma in situ (DCIS) is associated with invasive disease in more than half of invasive breast cancer cases. It is generally assumed that DCIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Labrosse, Julie, Morel, Charlotte, Lam, Thanh, Laas, Enora, Feron, Jean-Guillaume, Coussy, Florence, Lae, Marick, Reyal, Fabien, Hamy, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827327/
https://www.ncbi.nlm.nih.gov/pubmed/33435265
http://dx.doi.org/10.3390/cancers13020235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827327/
https://www.ncbi.nlm.nih.gov/pubmed/33435265
http://dx.doi.org/10.3390/cancers13020235

Ejemplares similares